University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Progranulin as a biomarker and potential therapeutic agent

Abella, V, Pino, J, Scotece, M, Conde, J, Lago, F, Gonzalez-Gay, MA, Mera, A, Gómez, R, Mobasheri, Ali and Gualillo, O (2017) Progranulin as a biomarker and potential therapeutic agent Drug Discovery Today, 22 (10). pp. 1557-1564.

[img] Text
PGRN_DDT_2017.05.09_Clean copy copia.doc - Accepted version Manuscript

Download (625kB)
PastedGraphic-2.pdf - Accepted version Manuscript

Download (53kB) | Preview
[img] Text
1-s2.0-S1359644617301113-main-4.pdf - Version of Record
Restricted to Repository staff only

Download (696kB)


Progranulin is a cysteine-rich secreted protein with diverse pleiotropic actions and participates in several processes, such as inflammation or tumorigenesis. Progranulin was first identified as a growth factor and, recently, it was characterised as an adipokine implicated in obesity, insulin resistance and rheumatic disease. At a central level, progranulin acts as a neurotropic and neuroprotective factor and protects from neural degeneration. In this review, we summarise the most recent research advances concerning the potential role of progranulin as a therapeutic target and biomarker in cancer, neurodegenerative and inflammatory diseases.

Item Type: Article
Divisions : Faculty of Health and Medical Sciences > School of Veterinary Medicine
Authors :
Abella, V
Pino, J
Scotece, M
Conde, J
Lago, F
Gonzalez-Gay, MA
Mera, A
Gómez, R
Gualillo, O
Date : 23 June 2017
DOI : 10.1016/j.drudis.2017.06.006
Copyright Disclaimer : © 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
Depositing User : Melanie Hughes
Date Deposited : 18 Oct 2017 10:35
Last Modified : 19 Jun 2019 14:44

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800